180 related articles for article (PubMed ID: 2104257)
1. Regulation of parathyroid cell gene expression in experimental uremia.
Shvil Y; Naveh-Many T; Barach P; Silver J
J Am Soc Nephrol; 1990 Jul; 1(1):99-104. PubMed ID: 2104257
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat.
Silver J; Naveh-Many T; Mayer H; Schmelzer HJ; Popovtzer MM
J Clin Invest; 1986 Nov; 78(5):1296-301. PubMed ID: 3771798
[TBL] [Abstract][Full Text] [Related]
4. Abnormal expression and regulation of vitamin D receptor in experimental uremia.
Szabó A; Ritz E; Schmidt-Gayk H; Reichel H
Nephron; 1996; 73(4):619-28. PubMed ID: 8856261
[TBL] [Abstract][Full Text] [Related]
5. In vivo regulation of chromogranin A messenger ribonucleic acid in the parathyroid by 1,25-dihydroxyvitamin D: studies in normal rats and in chronic renal insufficiency.
Soliman E; Canaff L; Fox J; Hendy GN
Endocrinology; 1997 Jun; 138(6):2596-600. PubMed ID: 9165053
[TBL] [Abstract][Full Text] [Related]
6. 1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia.
Szabo A; Merke J; Beier E; Mall G; Ritz E
Kidney Int; 1989 Apr; 35(4):1049-56. PubMed ID: 2709685
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of PHEX expression in bone and parathyroid gland by chronic renal insufficiency and 1,25-dihydroxyvitamin D3.
Brewer AJ; Canaff L; Hendy GN; Tenenhouse HS
Am J Physiol Renal Physiol; 2004 Apr; 286(4):F739-48. PubMed ID: 14693675
[TBL] [Abstract][Full Text] [Related]
8. Regulation of intestinal vitamin D receptor expression in experimental uraemia: effects of parathyroidectomy and administration of PTH.
Szabó A; Schmutz A; Pesian S; Schmidt-Gayk H; Ritz E; Reichel H
Nephrol Dial Transplant; 1998 Feb; 13(2):340-9. PubMed ID: 9509444
[TBL] [Abstract][Full Text] [Related]
9. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
Haq M; Kremer R; Goltzman D; Rabbani SA
J Clin Invest; 1993 Jun; 91(6):2416-22. PubMed ID: 8514854
[TBL] [Abstract][Full Text] [Related]
10. Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo.
Naveh-Many T; Marx R; Keshet E; Pike JW; Silver J
J Clin Invest; 1990 Dec; 86(6):1968-75. PubMed ID: 2174913
[TBL] [Abstract][Full Text] [Related]
11. Increased parathyroid expression of klotho in uremic rats.
Hofman-Bang J; Martuseviciene G; Santini MA; Olgaard K; Lewin E
Kidney Int; 2010 Dec; 78(11):1119-27. PubMed ID: 20631679
[TBL] [Abstract][Full Text] [Related]
12. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
Brown AJ; Zhong M; Finch J; Ritter C; Slatopolsky E
Endocrinology; 1995 Apr; 136(4):1419-25. PubMed ID: 7895652
[TBL] [Abstract][Full Text] [Related]
13. Direct upregulation of parathyroid calcium-sensing receptor and vitamin D receptor by calcimimetics in uremic rats.
Mendoza FJ; Lopez I; Canalejo R; Almaden Y; Martin D; Aguilera-Tejero E; Rodriguez M
Am J Physiol Renal Physiol; 2009 Mar; 296(3):F605-13. PubMed ID: 19091789
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone gene expression in hypophosphatemic rats.
Kilav R; Silver J; Naveh-Many T
J Clin Invest; 1995 Jul; 96(1):327-33. PubMed ID: 7615802
[TBL] [Abstract][Full Text] [Related]
15. Regulation of calcitonin gene transcription by vitamin D metabolites in vivo in the rat.
Naveh-Many T; Silver J
J Clin Invest; 1988 Jan; 81(1):270-3. PubMed ID: 2891728
[TBL] [Abstract][Full Text] [Related]
16. Daily or intermittent calcitriol administration during growth hormone therapy in rats with renal failure and advanced secondary hyperparathyroidism.
Sanchez CP; He YZ
J Am Soc Nephrol; 2005 Apr; 16(4):929-38. PubMed ID: 15728789
[TBL] [Abstract][Full Text] [Related]
17. Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency.
Mizobuchi M; Hatamura I; Ogata H; Saji F; Uda S; Shiizaki K; Sakaguchi T; Negi S; Kinugasa E; Koshikawa S; Akizawa T
J Am Soc Nephrol; 2004 Oct; 15(10):2579-87. PubMed ID: 15466262
[TBL] [Abstract][Full Text] [Related]
18. Intravenous 1,25(OH)2D therapy increases the intact parathyroid hormone secretion set point in hemodialyzed patients.
Brossard JH; Roy L; Lepage R; Gascon-Barré M; D'Amour P
Miner Electrolyte Metab; 1997; 23(1):25-32. PubMed ID: 9058366
[TBL] [Abstract][Full Text] [Related]
19. Regulation of calcitonin gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat.
Naveh-Many T; Raue F; Grauer A; Silver J
J Bone Miner Res; 1992 Oct; 7(10):1233-7. PubMed ID: 1360744
[TBL] [Abstract][Full Text] [Related]
20. Hyperphosphatemia-induced hyperparathyroidism in 5/6 nephrectomized rats: development of a new animal model.
Jiang Y; Wang M
Chin Med J (Engl); 2008 Dec; 121(23):2440-3. PubMed ID: 19102965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
